HiArc is set to unveil its innovative control system for diagnostic instruments, aimed at expediting the development process for medical devices, at the upcoming ADLM 2026 conference in Anaheim, California.
The HiArc Ctrl platform merges hardware and software to facilitate quicker transitions from concept to prototype for engineering teams. By offering a ready-to-use control architecture, it enables real-time interfacing with sensors and actuators, while ensuring compliance with regulated clinical workflows.
According to HiArc's product director, Tony Lacroix, the platform is built on extensive experience in developing medical instruments, reflecting a commitment to reducing the time spent on creating and validating control systems. This foundation is designed to support clients in moving from concept to commercialization more efficiently.
Additionally, HiArc will showcase its broader development capabilities, including engineering design and manufacturing, highlighting its role as a partner for diagnostic and life sciences innovators. President Nate Doemling emphasized the increasing pressure on diagnostics companies to innovate rapidly while managing regulatory and cost-related challenges, positioning HiArc as a resource to streamline these processes.
As the ADLM 2026 conference approaches, HiArc's offerings could significantly impact how diagnostic companies navigate the complexities of bringing new systems to market, promising to enhance both speed and efficiency in device development.